Roger L. Nation - Publications, H-index & Citations

Roger L. Nation

Monash University

83H指数

445论文数

2.7W被引数

收录论文 203

发表时间

Population Pharmacokinetic/Toxicodynamic Model for Polymyxin B in Critically Ill Patients to Identify the Risk of Nephrotoxicity 鲍莫西B在危重患者中的群体药代动力学/毒效动力学模型，以识别肾毒性风险

Clinical Pharmacology & Therapeutics

IF5.5

2025-06-16

OAAI

Patrick O. Hanafin; Ramya Mahadevan; Gauri G. Rao; Alexandre P. Zavascki; Ana Maria Sandri; Andrea Kwa; Marc H. Scheetz; Christine J. Kubin; Jayesh Shah; Benjamin P.Z. Cherng; Michael T. Yin; Jiping Wang; Lu Wang; David P. Calfee; Maureen Bolon; Anthony W. Purcell; Roger L. Nation; Jason M. Pogue; Jian Li; Keith S. Kaye

Disposition of colistin in critically-ill patients on sustained low-efficiency dialysis: A population pharmacokinetic study 在持续低效透析的危重患者中粘菌素的处置：一项群体药代动力学研究

Clinical Microbiology and Infection

IF8.5

2025-05-29

OAAI

Adhiratha Boonyasiri; Dominika T. Fuhs; Thummaporn Naorungroj; Lu Wang; Jiping Wang; Ranistha Ratanarat; Jian Li; Roger L. Nation; Visanu Thamlikitkul; Cornelia B. Landersdorfer

Effects of different resistance mechanisms on bacterial response to meropenem, ciprofloxacin, and their combination described by next-generation mechanism-based modelling 不同耐药机制对细菌对美罗培南、环丙沙星及其联合用药反应的影响，由下一代机制基础建模描述

International Journal of Antimicrobial Agents

IF4.6

2025-05-03

OAAI

Alice E. Terrill; Jessica R. Tait; Kate E. Rogers; Wee L. Lee; Carla López-Causapé; Xiaoyu Wang; Jiangning Song; Roger L. Nation; Antonio Oliver; Cornelia B. Landersdorfer

The effects of single and multiple resistance mechanisms on bacterial response to meropenem

CLINICAL MICROBIOLOGY AND INFECTION

IF8.5

2024-10-01

OAAI

Fuhs, Dominika T.; Cortes-Lara, Sara; Tait, Jessica R.; Rogers, Kate E.; Lopez-Causape, Carla; Lee, Wee Leng; Shackleford, David M.; Nation, Roger L.; Oliver, Antonio; Landersdorfer, Cornelia B.

Population Pharmacokinetic Modeling of Cefepime, Meropenem, and Piperacillin-Tazobactam in Patients With Cystic Fibrosis 囊性纤维化患者中头孢吡肟，美罗培南和哌拉西林-他唑巴坦的群体药代动力学模型

JOURNAL OF INFECTIOUS DISEASES

IF4.5

2024-09-30

PREAI

Rolsma, Stephanie L.; Sokolow, Andrew; Patel, Pratish C.; Sokolow, Katherine; Jimenez-Truque, Natalia; Fissell, William H.; Ryan, Vivian; Kirkpatrick, Carl M.; Nation, Roger L.; Gu, Kenan; Teresi, Mary; Fishbane, Nicholas; Kontos, Marissa; An, Guohua; Winokur, Patricia; Landersdorfer, Cornelia B.; Creech, C. Buddy

Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2024-04-03

OAAI

Tait, Jessica R.; Anderson, Dovile; Nation, Roger L.; Creek, Darren J.; Landersdorfer, Cornelia B.

Distinguishing Inducible and Non-Inducible Resistance to Colistin in Pseudomonas aeruginosa by Quantitative and Systems Pharmacology Modeling at Low and Standard Inocula 通过定量和系统药理学建模在低和标准接种物中区分铜绿假单胞菌对粘菌素的诱导型和非诱导型抗性

JOURNAL OF PHARMACEUTICAL SCIENCES

IF3.8

2024-01-01

PREAI

Bulitta, Jurgen B.; Shin, Eunjeong; Bergen, Phillip J.; Lang, Yinzhi; Forrest, Alan; Tsuji, Brian T.; Moya, Bartolome; Li, Jian; Nation, Roger L.; Landersdorfer, Cornelia B.

Clinical pharmacological considerations in an early intravenous to oral antibiotic switch: are barriers real or simply perceived?

CLINICAL MICROBIOLOGY AND INFECTION

IF8.5

2023-09-01

PREAI

Landersdorfer, Cornelia B.; Gwee, Amanda; Nation, Roger L.

A population pharmacokinetic model of polymyxin B based on prospective clinical data to inform dosing in hospitalized patients

CLINICAL MICROBIOLOGY AND INFECTION

IF8.5

2023-09-01

OAAI

Hanafin, Patrick O.; Kwa, Andrea; Zavascki, Alexandre P.; Sandri, Ana Maria; Scheetz, Marc H.; Kubin, Christine J.; Shah, Jayesh; Cherng, Benjamin P. Z.; Yin, Michael T.; Wang, Jiping; Wang, Lu; Calfee, David P.; Bolon, Maureen; Pogue, Jason M.; Purcell, Anthony W.; Nation, Roger L.; Li, Jian; Kaye, Keith S.; Rao, Gauri G.

Ceftolozane-Tazobactam against Pseudomonas aeruginosa Cystic Fibrosis Clinical Isolates in the Hollow-Fiber Infection Model: Challenges Imposed by Hypermutability and Heteroresistance 头孢特咯瓒-他唑巴坦对中空纤维感染模型中铜绿假单胞菌囊性纤维化临床分离株的影响: 超突变性和异质性带来的挑战

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2023-08-17

OAAI

Tait, Jessica R. R.; Harper, Marina; Cortes-Lara, Sara; Rogers, Kate E. E.; Lopez-Causape, Carla; Smallman, Thomas R. R.; Lang, Yinzhi; Lee, Wee Leng; Zhou, Jieqiang; Bulitta, Jurgen B.; Nation, Roger L. L.; Boyce, John D. D.; Oliver, Antonio; Landersdorfer, Cornelia B. B.

Population pharmacokinetics and target attainment analyses to identify a rational empirical dosing strategy for cefepime in critically ill patients 群体药代动力学和目标达成分析，以确定重症患者头孢吡肟的合理经验给药策略

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

IF3.6

2023-04-18

OAAI

An, Guohua; Creech, C. Buddy; Wu, Nan; Nation, Roger L.; Gu, Kenan; Nalbant, Demet; Jimenez-Truque, Natalia; Fissell, William; Patel, Pratish C.; Fishbane, Nicholas; Watanabe, Amy; Rolsma, Stephanie; Kirkpatrick, Carl M. J.; Landersdorfer, Cornelia B.; Winokur, Patricia

Population Pharmacokinetics and Outcomes of Critically Ill Pediatric Patients Treated with Intravenous Colistin at Higher than Recommended Doses(VOL 65, e00002-21,2021)

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2023-02-16

OAAI

Antachopoulos, Charalampos; Geladari, Anastasia; Landersdorfer, Cornelia B.; Volakli, Eleni; Ilia, Stavroula; Gikas, Evangelos; Gika, Helen; Sdougka, Maria; Nation, Roger L.; Roilides, Emmanuel

Evaluation of Empirical Dosing Regimens for Meropenem in Intensive Care Unit Patients Using Population Pharmacokinetic Modeling and Target Attainment Analysis 基于群体药代动力学模型与目标达标分析对重症监护病房患者美罗培南经验性给药方案的评价

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2023-01-24

OAAI

An, Guohua; Creech, C. Buddy; Wu, Nan; Nation, Roger L.; Gu, Kenan; Nalbant, Demet; Jimenez-Truque, Natalia; Fissell, William; Rolsma, Stephanie; Patel, Pratish C.; Watanabe, Amy; Fishbane, Nicholas; Kirkpatrick, Carl M. J.; Landersdorfer, Cornelia B.; Winokur, Patricia

A Systems-Based Analysis of Mono- and Combination Therapy for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections 单药和联合治疗耐碳青霉烯类肺炎克雷伯菌血流感染的系统分析

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2022-10-18

OAAI

Luterbach, Courtney L.; Qiu, Hongqiang; Hanafin, Patrick O.; Sharma, Rajnikant; Piscitelli, Joseph; Lin, Feng-Chang; Ilomaki, Jenni; Cober, Eric; Salata, Robert A.; Kalayjian, Robert C.; Watkins, Richard R.; Doi, Yohei; Kaye, Keith S.; Nation, Roger L.; Bonomo, Robert A.; Landersdorfer, Cornelia B.; van Duin, David; Rao, Gauri G.

Penicillin G concentrations required for prophylaxis against Group A Streptococcus infection evaluated using a hollow fibre model and mathematical modelling

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

IF3.6

2022-04-26

OAAI

Tait, Jessica R.; Barnett, Timothy C.; Rogers, Kate E.; Lee, Wee Leng; Page-Sharp, Madhu; Manning, Laurens; Boyd, Ben J.; Carapetis, Jonathan R.; Nation, Roger L.; Landersdorfer, Cornelia B.

A synthetic lipopeptide targeting top-priority multidrug-resistant Gram-negative pathogens 靶向多重耐药革兰氏阴性病原体的合成脂肽

NATURE COMMUNICATIONS

IF15.7

2022-03-25

OAAI

Roberts, Kade D.; Zhu, Yan; Azad, Mohammad A. K.; Han, Mei-Ling; Wang, Jiping; Wang, Lynn; Yu, Heidi H.; Horne, Andrew S.; Pinson, Jo-Anne; Rudd, David; Voelcker, Nicolas H.; Patil, Nitin A.; Zhao, Jinxin; Jiang, Xukai; Lu, Jing; Chen, Ke; Lomovskaya, Olga; Hecker, Scott J.; Thompson, Philip E.; Nation, Roger L.; Dudley, Michael N.; Griffith, David C.; Velkov, Tony; Li, Jian

Simulated Intravenous versus Inhaled Tobramycin with or without Intravenous Ceftazidime Evaluated against Hypermutable Pseudomonas aeruginosa via a Dynamic Biofilm Model and Mechanism-Based Modeling 通过动态生物膜模型和基于机制的建模评估了模拟静脉内与吸入妥布霉素联合或不联合静脉内头孢他啶对超突变铜绿假单胞菌的影响

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2022-03-15

OAAI

Bilal, Hajira; Tait, Jessica R.; Lang, Yinzhi; Zhou, Jieqiang; Bergen, Phillip J.; Peleg, Anton Y.; Bulitta, Jurgen B.; Oliver, Antonio; Nation, Roger L.; Landersdorfer, Cornelia B.

Effect of Different Piperacillin-Tazobactam Dosage Regimens on Synergy of the Combination with Tobramycin against Pseudomonas aeruginosa for the Pharmacokinetics of Critically Ill Patients in a Dynamic Infection Model 动态感染模型中不同哌拉西林-他唑巴坦给药方案对联合妥布霉素抗铜绿假单胞菌药动学协同作用的影响

ANTIBIOTICS-BASEL

IF4.6

2022-01-13

OAAI

Tait, Jessica R.; Bilal, Hajira; Rogers, Kate E.; Lang, Yinzhi; Kim, Tae-Hwan; Zhou, Jieqiang; Wallis, Steven C.; Bulitta, Juergen B.; Kirkpatrick, Carl M. J.; Paterson, David L.; Lipman, Jeffrey; Bergen, Phillip J.; Roberts, Jason A.; Nation, Roger L.; Landersdorfer, Cornelia B.

Assessing the predictive performance of population pharmacokinetic models for intravenous polymyxin B in critically ill patients

CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY

IF3

2021-11-23

OAAI

Hanafin, Patrick O.; Nation, Roger L.; Scheetz, Marc H.; Zavascki, Alexandre P.; Sandri, Ana M.; Kwa, Andrea L.; Cherng, Benjamin P. Z.; Kubin, Christine J.; Yin, Michael T.; Wang, Jiping; Li, Jian; Kaye, Keith S.; Rao, Gauri G.

Pharmacodynamics of ceftazidime plus tobramycin combination dosage regimens against hypermutable Pseudomonas aeruginosa isolates at simulated epithelial lining fluid concentrations in a dynamic in vitro infection model 在动态体外感染模型中，头孢他啶和妥布霉素联合给药方案在模拟上皮衬液浓度下对超突变铜绿假单胞菌分离株的药效学

JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE

IF3.2

2021-09-01

OAAI

Tait, Jessica R.; Bilal, Hajira; Kim, Tae Hwan; Oh, Abigail; Peleg, Anton Y.; Boyce, John D.; Oliver, Antonio; Bergen, Phillip J.; Nation, Roger L.; Landersdorfer, Cornelia B.

研究方向